Vocinti Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Vonoprazan

Indications/Uses

Gastric & duodenal ulcer. Reflux esophagitis treatment & maintenance. Recurrence prevention of gastric or duodenal ulcer during NSAIDs administration. Adjunct to H. pylori eradication.

Dosage/Direction for Use

Adult Gastric ulcer 20 mg once daily up to 8 wk. Duodenal ulcer 20 mg once daily up to 6 wk. Reflux esophagitis 20 mg once daily. Limit administration to 4 wk. May be continued for up to 8 wk when the effect is insufficient. Maintenance in recurrence & relapse: 10 mg once daily. May be increased to 20 mg once daily when efficacy is inadequate. Recurrence prevention of gastric or duodenal ulcer during NSAIDs administration 10 mg once daily. Adjunct to H. pylori eradication Vonoprazan 20 mg w/ amoxicillin & clarithromycin at the same time bd for 7 days. Alternatively, if treatment fails, may give vonoprazan 20 mg w/ amoxicillin & metronidazole at the same time bd for 7 days.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

MIMS Class

Antacids, Antireflux Agents & Antiulcerants

ATC Classification

A02BC08 - vonoprazan ; Belongs to the class of potassium-competitive acid blocker. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

Regulatory Classification

POM

Presentation/Packing

Form

Vocinti FC tab 10 mg

Packing/Price

1's

Form

Vocinti FC tab 20 mg

Packing/Price

1's

Vocinti

vonoprazan

Manufacturer:

Takeda